AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II Biotech Investing
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease Pharmaceutical Investing
Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas Pharmaceutical Investing
Xanthic Biopharma Inc. Announces LOI with Licensed Producer, Green Mile Solutions LLC, for Production and Sale of Xanthic-Infused Products in Oregon, Nevada and Ohio Cannabis Investing News
Xanthic Biopharma Inc. Closes First Tranche of Oversubscribed Private Placement Cannabis Investing News
Xanthic Biopharma Inc. to Commence Trading on the Canadian Securities Exchange Cannabis Investing News
Adamas Announces Final Results from the Two-Year Phase 3 Open-Label Study of GOCOVRI Pharmaceutical Investing
Flexion Therapeutics Announces Publication of Results from Pivotal Phase 3 Study of ZILRETTA Biotech Investing
